Posted by Michael Wonder on 31 Jan 2023
Schedule of Pharmaceutical Benefits - 1 February 2023
1 February 2023 - The February 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The February issue of the Schedule includes a few major new/revised listings:
- Beclomethasone dipropionate with eformoterol fumarate dihydrate (Fostair) - new formulation
- Opicapone (Ongentys) - new medicine
The February issue is dominated by the listing of multiple generic brands of lenalidomide,.
